A systematic review of comparative studies of tiotropium Respimat® and tiotropium HandiHaler® in patients with chronic obstructive pulmonary disease: Does inhaler choice matter?
Số trang: 17
Loại file: pdf
Dung lượng: 1.08 MB
Lượt xem: 9
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
In many countries worldwide, the long-acting anticholinergic drug tiotropium is available as a dry powder formulation delivered by means of the HandiHaler® inhalation device and as an aqueous solution delivered via the Respimat® Soft Mist™ Inhaler.
Nội dung trích xuất từ tài liệu:
A systematic review of comparative studies of tiotropium Respimat® and tiotropium HandiHaler® in patients with chronic obstructive pulmonary disease: Does inhaler choice matter?
Nội dung trích xuất từ tài liệu:
A systematic review of comparative studies of tiotropium Respimat® and tiotropium HandiHaler® in patients with chronic obstructive pulmonary disease: Does inhaler choice matter?
Tìm kiếm theo từ khóa liên quan:
BMC Pulmonary Medicine Chronic obstructive pulmonary disease Tiotropium Respimat® Tiotropium HandiHaler® Soft Mist™ InhalerTài liệu có liên quan:
-
9 trang 31 0 0
-
Quality of life is associated with physical activity and fitness in cystic fibrosis
9 trang 30 0 0 -
Clinical impact of cardiovascular disease on patients with bronchiectasis
7 trang 30 0 0 -
7 trang 30 0 0
-
7 trang 30 0 0
-
11 trang 29 0 0
-
9 trang 29 0 0
-
Efect of periodontal therapy on COPD outcomes: A systematic review
16 trang 25 0 0 -
10 trang 25 0 0
-
8 trang 24 0 0